Heparan sulphate proteoglycan (HSPG) facilitates the interaction between heparin-binding epidermal growth factor-like growth factor (HB-EGF) and EGFR, leading to the differentiation of NB cells via an activation of ERK1/2 and STAT3 pathways [182]. Here, EGFR is linked to neuroblastoma.